Advanced or Metastatic EP-NEC

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Advanced or Metastatic EP-NEC trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

UnknownPhase 2

NCT05142865

Camrelizumab Combined With Chemotherapy and Apatinib for Extrapulmonary Neuroendocrine Carcinomas

This is an open-label，single-arm, phase II exploratory study that evaluates the efficacy and safety of Camrelizumab combined with Chemotherapy （carboplatin or c…

China30 participantsStarted 2022-01-14

Treatment: Camrelizumab, Etoposide